Key result
Targeting cardiomyocyte cell cycle pathways shows promise for promoting heart regeneration in heart failure.
Why the study?
Current treatments cannot address the extensive loss of functioning cardiomyocytes in heart failure due to the adult heart's limited regenerative capacity, motivating interest in cell cycle regulation and cardiomyocyte proliferation.
Stimulating cardiomyocyte proliferation by targeting cell cycle regulation represents a potential therapeutic strategy for heart regeneration in heart failure.
No takes yet. Share an insight, caveat, or question.
May inform future regenerative HF therapies; leaves open clinical translation from preclinical data.
Zhu et al. (2024) conducted a review in Heart failure. Cardiomyocyte cell cycle regulation was evaluated. Targeting cardiomyocyte cell cycle regulation through molecular, epigenetic, and metabolic pathways presents a promising therapeutic strategy for promoting heart regeneration in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: